Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?

by Aurélien Mary, Aurélien Mary, Lucie Hénaut, Jean-Luc Schmit, Jean-Luc Schmit, Jean-Philippe Lanoix, Jean-Philippe Lanoix, Michel Brazier, Michel Brazier
Published 2020-05-01

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals

by Etienne Brochot, Etienne Brochot, Baptiste Demey, Baptiste Demey, Antoine Touzé, Sandrine Belouzard, Jean Dubuisson, Jean-Luc Schmit, Jean-Luc Schmit, Gilles Duverlie, Gilles Duverlie, Catherine Francois, Catherine Francois, Sandrine Castelain, Sandrine Castelain, Francois Helle
Published 2020-10-01